Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Microsoft stock price forecast: MSFT climbs as AI trade returns — payrolls and earnings in focus

Microsoft stock price forecast: MSFT climbs as AI trade returns — payrolls and earnings in focus

Microsoft shares rose 1.2% to $484.34 in Wednesday afternoon trading, tracking gains in big-cap tech as investors rotated back into AI-linked stocks. The Midcontinent Independent System Operator said it would use Microsoft technology to help manage its power grid. Microsoft shares remain below their 50-day moving average of $494.66. The company’s next earnings report is expected January 28.
BMNR stock forecast: BitMine slides as crypto cools, with a Jan. 14 vote looming

BMNR stock forecast: BitMine slides as crypto cools, with a Jan. 14 vote looming

BitMine Immersion Technologies shares fell 5.2% to $30.65 in Wednesday afternoon trading, tracking declines in ether and bitcoin. Shareholders face a Jan. 14 deadline to vote on raising authorized shares to 50 billion from 500 million ahead of the company’s annual meeting. Options markets signal high volatility into Friday’s expiry. BitMine reported holding over 4.1 million ether and 192 bitcoin as of Jan. 4.
ASTS stock price forecast: Scotiabank downgrade hits AST SpaceMobile as targets split wide

ASTS stock price forecast: Scotiabank downgrade hits AST SpaceMobile as targets split wide

AST SpaceMobile shares fell about 11% Wednesday after Scotiabank downgraded the stock and set a $45.60 target, citing concerns over valuation and cash burn. Shares traded at $86.72 in the afternoon, down from a high of $95.25. AT&T plans a limited beta launch of AST’s direct-to-device satellite service in the first half of 2026. Investors await deployment milestones and the next earnings update, expected March 26.
Broadcom stock price forecast: AVGO tests $350 after $4.5B bond pricing and Wi‑Fi 8 launch

Broadcom stock price forecast: AVGO tests $350 after $4.5B bond pricing and Wi‑Fi 8 launch

Broadcom shares rose 0.9% to $346.8 after the company priced a $4.5 billion, four-part senior notes sale for debt repayment, with closing set for Jan. 13. The chipmaker also launched new Wi‑Fi 8 chips targeting AI tasks in home networks. Traders are watching support in the mid-$340s and a possible $350 retest ahead of the next earnings update.
Oil price forecast: Brent, WTI slide on Trump Venezuela move as 2026 surplus looms

Oil price forecast: Brent, WTI slide on Trump Venezuela move as 2026 surplus looms

Oil prices fell Wednesday after President Trump said Venezuela would send up to 50 million barrels of sanctioned crude to the U.S., raising oversupply concerns. Brent dropped 0.7% to $60.31 a barrel, WTI fell 1.3% to $56.39. U.S. crude stocks dropped last week, but gasoline and distillate inventories rose sharply, EIA reported. Trump is set to meet oil company executives at the White House on Friday, sources said.
Tesla stock price forecast swings: Wall Street split from $25 to $600 ahead of earnings

Tesla stock price forecast swings: Wall Street split from $25 to $600 ahead of earnings

Tesla shares rose 0.6% to $435.40 Wednesday as Wall Street analysts issued sharply different price targets ahead of the company’s Jan. 28 earnings report. New Street Research raised its target to $600, while GLJ Research lifted its target to $25.28 but maintained a sell rating. Tesla earlier reported Q4 deliveries of 418,227 vehicles and record energy storage deployment. The company continues to face pressure from Nvidia’s CES announcements and lost the global EV sales lead to BYD.
Silver price forecast: HSBC lifts 2026 view as spot silver slides 4% ahead of U.S. payrolls

Silver price forecast: HSBC lifts 2026 view as spot silver slides 4% ahead of U.S. payrolls

Spot silver dropped 4.1% to $77.93 an ounce Wednesday after a recent surge and as the dollar strengthened. HSBC raised its 2026 average silver price forecast to $68.25 but warned of ongoing volatility. U.S. job openings fell by 303,000 in November, while private payrolls missed estimates. Silver hit a record $83.62 on Dec. 29, fueled by safe-haven demand after U.S. strikes in Venezuela.
Nvidia price forecast: Analysts keep $270–$352 targets as China H200 orders turn into the new risk

Nvidia price forecast: Analysts keep $270–$352 targets as China H200 orders turn into the new risk

Nvidia shares climbed 1.3% to $189.59 Wednesday after brokerages raised price targets following CES, with the highest at $352. CEO Jensen Huang said next-gen chips are in full production, aiming for a fivefold AI performance boost. Reports said China asked local firms to halt H200 orders, while U.S. export licenses remain pending. Nvidia’s principal accounting officer sold 80,000 shares last week under a pre-set plan.
Europa Clipper’s UV look at Comet 3I/ATLAS backs water-ice call as radio “technosignature” scan finds none

Europa Clipper’s UV look at Comet 3I/ATLAS backs water-ice call as radio “technosignature” scan finds none

NASA’s Europa Clipper spacecraft detected hydrogen and oxygen in the coma of interstellar comet 3I/ATLAS using its ultraviolet spectrograph in November, the SETI Institute said Tuesday. The comet, only the third known interstellar object to pass through the solar system, showed no signs of breaking apart. Europe’s JUICE mission and the Green Bank Telescope also observed the comet last fall. No artificial radio signals were found.
7 January 2026
Netflix stock price forecast: NFLX stuck near $90 as Warner vote backs deal and earnings loom

Netflix stock price forecast: NFLX stuck near $90 as Warner vote backs deal and earnings loom

Netflix shares slipped 0.2% to $90.50 after Warner Bros. Discovery’s board urged shareholders to reject Paramount Skydance’s bid and back Netflix’s offer. Netflix said it has filed required antitrust paperwork and is talking with U.S. and EU regulators. The company reports fourth-quarter results and its outlook on Jan. 20. NFLX trades near the bottom of its 52-week range, below key moving averages.
AMD stock forecast: Shares dip as CES AI-chip rollout meets profit-taking ahead of Feb. 3 earnings

AMD stock forecast: Shares dip as CES AI-chip rollout meets profit-taking ahead of Feb. 3 earnings

AMD shares fell 2.4% to $209.26 in Wednesday afternoon trading, trailing gains in Nvidia and Intel after AMD’s CES launch of new AI chips. The company will report fiscal Q4 and full-year 2025 results on Feb. 3. Investors are watching for guidance on AI chip shipments and margins. Intel unveiled new laptop chips at CES, intensifying competition.
1 6 7 8 9 10 352

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop